A carregar...
Is metastatic pancreatic cancer an untargetable malignancy?
Metastatic pancreatic cancer (MPC) is one of the most aggressive malignancies, known to be chemo-resistant and have been recently considered resistant to some targeted therapies (TT). Erlotinib combined to gemcitabine is the only targeted therapy that showed an overall survival benefit in MPC. New t...
Na minha lista:
| Publicado no: | World J Gastrointest Oncol |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Baishideng Publishing Group Inc
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4789615/ https://ncbi.nlm.nih.gov/pubmed/26989465 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4251/wjgo.v8.i3.297 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|